Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
BioSpace
59m
Pfizer’s Subcutaneous PD-1 Blocker Aces Phase III in Bladder Cancer, Carves Niche Versus Keytruda
If approved, Pfizer’s sasanlimab will distinguish itself from Merck’s blockbuster Keytruda as the first PD-1 inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
US adds 256K jobs in Dec
Los Angeles wildfire updates
California fires: How to help
'Pizzagate' gunman killed
1.2M-year-old ice core
Freed after brief detention
Ski patrol strike ends
Mar 9: Canada's PM decision
Sues over ‘Rust' prosecution
WI triple homicide arrest
Economic growth forecast
La Nina finally arrives
US settles w/ Johns Hopkins
Must face defamation suit
Vance resigns from Senate
Hosts AfD leader on X
Presidential palace attack
Earth's hottest year: 2024
Quits climate group
Settles opioid lawsuit
SCOTUS rejects Trump’s bid
Bill to sanction ICC OK'd
Sworn in as NH governor
Judge scraps Title IX rules
Orange Bowl win
ACLU sues DeSantis
Wycheck had CTE
Singer Anita Bryant dies
Feedback